1. Home
  2. HRMY vs KWR Comparison

HRMY vs KWR Comparison

Compare HRMY & KWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$36.78

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Quaker Houghton

KWR

Quaker Houghton

HOLD

Current Price

$160.01

Market Cap

2.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
KWR
Founded
2017
1918
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.5B
IPO Year
2020
1985

Fundamental Metrics

Financial Performance
Metric
HRMY
KWR
Price
$36.78
$160.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
4
Target Price
$49.75
$149.25
AVG Volume (30 Days)
615.1K
119.7K
Earning Date
02-24-2026
02-23-2026
Dividend Yield
N/A
1.28%
EPS Growth
50.44
N/A
EPS
3.17
N/A
Revenue
$825,944,000.00
$1,864,242,000.00
Revenue This Year
$23.29
$3.44
Revenue Next Year
$15.98
$4.15
P/E Ratio
$11.58
N/A
Revenue Growth
21.13
0.08
52 Week Low
$25.52
$95.91
52 Week High
$40.93
$162.10

Technical Indicators

Market Signals
Indicator
HRMY
KWR
Relative Strength Index (RSI) 48.42 64.83
Support Level $35.16 $149.96
Resistance Level $37.08 $162.10
Average True Range (ATR) 1.43 5.07
MACD -0.21 0.90
Stochastic Oscillator 43.22 91.54

Price Performance

Historical Comparison
HRMY
KWR

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About KWR Quaker Houghton

Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.

Share on Social Networks: